LOKELMA (sodium zirconium cyclosilicate) is a specifically formulated oral suspension for effective hyperkalemia management in adults, provided in convenient, foil-lined 10g packets.
Designed as a potent potassium removing agent, LOKELMA offers a targeted approach to controlling high potassium levels, with each packet containing a white to grey powder ready for suspension.
Manufactured by AstraZeneca Pharmaceuticals, LOKELMA represents a leading solution in the treatment of hyperkalemia, ensuring quality and efficacy.
